Journal article
M. Sadagurski, Taylor Landeryou, Gillian Cady, J. Kopchick, E. List, D. Berryman, A. Bartke, Richard A. Miller
Aging Cell, 2015
Aging Cell, 2015
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Sadagurski, M., Landeryou, T., Cady, G., Kopchick, J., List, E., Berryman, D., … Miller, R. A. (2015). Growth hormone modulates hypothalamic inflammation in long‐lived pituitary dwarf mice. Aging Cell.
Chicago/Turabian
Click to copy
Sadagurski, M., Taylor Landeryou, Gillian Cady, J. Kopchick, E. List, D. Berryman, A. Bartke, and Richard A. Miller. “Growth Hormone Modulates Hypothalamic Inflammation in Long‐Lived Pituitary Dwarf Mice.” Aging Cell (2015).
MLA
Click to copy
Sadagurski, M., et al. “Growth Hormone Modulates Hypothalamic Inflammation in Long‐Lived Pituitary Dwarf Mice.” Aging Cell, 2015.
BibTeX Click to copy
@article{m2015a,
title = {Growth hormone modulates hypothalamic inflammation in long‐lived pituitary dwarf mice},
year = {2015},
journal = {Aging Cell},
author = {Sadagurski, M. and Landeryou, Taylor and Cady, Gillian and Kopchick, J. and List, E. and Berryman, D. and Bartke, A. and Miller, Richard A.}
}
Abstract
Mice in which the genes for growth hormone (GH) or GH receptor (GHR−/−) are disrupted from conception are dwarfs, possess low levels of IGF‐1 and insulin, have low rates of cancer and diabetes, and are extremely long‐lived. Median longevity is also increased in mice with deletion of hypothalamic GH‐releasing hormone (GHRH), which leads to isolated GH deficiency. The remarkable extension of longevity in hypopituitary Ames dwarf mice can be reversed by a 6‐week course of GH injections started at the age of 2 weeks. Here, we demonstrate that mutations that interfere with GH production or response, in the Snell dwarf, Ames dwarf, or GHR−/− mice lead to reduced formation of both orexigenic agouti‐related peptide (AgRP) and anorexigenic proopiomelanocortin (POMC) projections to the main hypothalamic projection areas: the arcuate nucleus (ARH), paraventricular nucleus (PVH), and dorsomedial nucleus (DMH). These mutations also reduce hypothalamic inflammation in 18‐month‐old mice. GH injections, between 2 and 8 weeks of age, reversed both effects in Ames dwarf mice. Disruption of GHR specifically in liver (LiGHRKO), a mutation that reduces circulating IGF‐1 but does not lead to lifespan extension, had no effect on hypothalamic projections or inflammation, suggesting an effect of GH, rather than peripheral IGF‐1, on hypothalamic development. Hypothalamic leptin signaling, as monitored by induction of pStat3, is not impaired by GHR deficiency. Together, these results suggest that early‐life disruption of GH signaling produces long‐term hypothalamic changes that may contribute to the longevity of GH‐deficient and GH‐resistant mice.